• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconFDA

FDA

Page 11 of 35
A major baby formula plant is reopening. But a real solution to the supply shortage is still months away
HealthA major baby formula plant is reopening. But a real solution to the supply shortage is still months away
By Colin LodewickMay 17, 2022
Boy receives COVID-19 vaccine
HealthFDA authorizes Pfizer booster for children ages 5 to 11
By Lauran Neergaard and The Associated PressMay 17, 2022
Child receives COVID-19 vaccine
HealthFDA sets June meetings on COVID vaccines for youngest kids
By The Associated PressApril 29, 2022
COVID-19 vaccine for kids
HealthModerna asks the FDA to authorize low doses of its COVID vaccine for kids under 6
By Lauran Neergaard and The Associated PressApril 28, 2022
Portrait of Dr. Peter Marks
HealthTime is running short to make COVID variant vaccines for the coming autumn wave, FDA experts warn
By Ian MountApril 7, 2022
Man receives Pfizer COVID vaccine
HealthFDA approves additional Pfizer and Moderna COVID boosters for adults 50 and older
By Lauran Neergaard, Matthew Perrone and The Associated PressMarch 29, 2022
Vaccine Antibody treatment Evusheld
HealthNew drug that prevents you from catching COVID-19 gets green light in Europe — but it’s been in the U.S. for months and hardly anyone knows about it
By Sophie MellorMarch 29, 2022
Children get their temperatures taken at school
HealthFDA postpones meeting on Pfizer COVID shot for kids under 5
By Fiona Rutherford and BloombergFebruary 11, 2022
Moderna vaccine full FDA approval
HealthModerna COVID-19 vaccine gets full approval from the FDA
By Matthew Perrone and The Associated PressJanuary 31, 2022
Inside Moderna’s plan to battle Omicron and develop a booster that works against any future variants
MagazineInside Moderna’s plan to battle Omicron and develop a booster that works against any future variants
By Erika FryJanuary 30, 2022
Computer artwork of a molecule of Lysergic acid diethylamide (LSD).
HealthFDA clears LSD-based anxiety drug for clinical trials
By Chris MorrisJanuary 26, 2022
Woman using home COVID-19 testing kit on her teenage daughter.
HealthHere’s when to expect at-home tests that are better at detecting Omicron
By Andrew MarquardtJanuary 18, 2022
Pfizer booster eligibility
HealthFDA clears Pfizer boosters for 12-to-15 year-olds
By Lauran Neergaard and The Associated PressJanuary 3, 2022
Merck covid 19 pill
HealthFDA authorizes Merck COVID pill a day after approving Pfizer’s
By Matthew Perrone and The Associated PressDecember 23, 2021
Pfizer logo pill
HealthPfizer pill becomes first FDA-approved home COVID treatment
By Matthew Perrone and The Associated PressDecember 22, 2021
1...
  • 9
  • 10
  • 11
  • 12
  • 13
...35
Most Popular
Politics
'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuzplaceholder alt text
By Fortune EditorsApril 11, 2026
Future of Work
Palantir CEO says AI ‘will destroy’ humanities jobs but there will be ‘more than enough jobs’ for people with vocational trainingplaceholder alt text
By Fortune EditorsApril 11, 2026
Real Estate
The 'affordability economy' has created a housing market nobody predicted: Prices collapsing in the Sun Belt, soaring in the Rust Beltplaceholder alt text
By Fortune EditorsApril 11, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.